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Multiple pregnancies with higher risk of preterm birth and the associated higher morbidity 
have been a major obstacle from the early days of in vitro fertilization. A good strategy to 
avoid multiple pregnancies is elective single embryo t ansfer and cryopreservation of spare 
embryos. Important factors in adopting this strategy are good counselling of the patients and 
the selection of embryos with high implantation potential.  Technical advances in embryo 
selection have been described during recent years, time lapse monitoring and genetic 
assessment of the embryos being the most important achievements. With these studies we 
have gained new information on early embryos.  However, at present, there is insufficient 
evidence to recommend the routine use of these new techniques. The ultimate goal of 
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More than seven million children have been born worldwide as the result of assisted 
reproduction technology (ART). Multiple pregnancies with higher risk of preterm birth and 
the associated higher morbidity have been a major obstacle from the early days of IVF (1). 
The high multiple pregnancy rate of ART is a significant public health issue and, as a result, 
single embryo transfer (SET) should be encouraged. However, SET also demands more 
consistent methods for identifying the best embryo for transfer, as well as improved methods 
for predicting live-birth. 
 
However, SET is not the only solution to the adverse perinatal outcome in IVF children, as 
growing evidence has shown that ART singletons also have a slightly higher risk of preterm 
birth, low-birth weight, being small for gestational age, and an increased rate of congenital 




Recently, higher neonatal birth weight was reported after transfer of frozen thawed 
embryos. Ref.: Pinborg A, Henningsen AA, Loft A, Malchau SS, Forman J, Andersen 
AN. Large baby syndrome in singletons born after frozen embryo transfer (FET): is it 
due to maternal factors or the cryotechnique? Hum Reprod. 2014 Mar;29(3):618-27. 
 
ESET is leading to more transfers of previously frozen embryos. So in contrast to the 
current situation, in which the birth weight of newborn children is somewhat lower, if 
they were conceived in a fresh cycle, we are moving towards the opposite situation. 
Shouldn’t we add this to the review? 
 
 
The causes of the poorer outcome in ART singletons are probably multifactorial. Subfertility 
is a major risk factor for adverse perinatal outcome in ART singletons, however, even in the 
same mother an ART singleton has a poorer outcome than the non-ART sibling; hence, 
factors related to the hormone stimulation and/or IVF methods per se also may play a part (1). 
The major concern is whether the IVF techniques themselves could have negative impacts on 
the ART offspring. 
 
To encourage elective SET, several methods have been studied to identify and select the best 















genetic testing. A trend of increasing blastocyst transfers combined with improvements in 
embryo selection techniques results in increases in lective SET. It also allows clinics to more 
confidently offer SET (4).  
 
Despite continuing technical advances, however, it is l kely that small but potentially 
significant live-birth rate differences will persist between single and double embryo transfer if 
we continue to emphasize pregnancy rates per transfer i stead of cumulative pregnancy rates 
(derived from the fresh and frozen cycles) per oocyte pick-up Predictive models suggest that 
cumulative live-birth rates with the use of sequential SET are equal or superior to DET (5). 
Further studies confirming this prediction will help to convince physicians, patients, and 
health care providers of the benefits and feasibility of SET, even if this strategy requires 
additional transfers and a slightly longer time to pregnancy.  
 
A. How elective single embryo transfer has evolved  
 
The implementation of eSET in different countries ha  occurred in different ways. In Finland 
the initiative for reducing the number of transferred embryos came from the IVF clinics 
taking the responsibility for the safety of ART, initially when treating high-risk patients. The 
results of the preliminary experience convinced to continue and eSET strategy was accepted 
gradually nationwide (6).  In Sweden the implementation of eSET in a larger scale occurred 
following the new rules from the National Board of Health and Welfare, which instructed that 
in ART only one embryo should be transferred, except in cases where the risk for a twin 
pregnancy is estimated to be low. The implementation of SET in Sweden was easier than one 
had imagined (7). There is another kind of example from Belgium where eSET was 
introduced in few large infertility centres since 1998 (8). From July 2003 onwards a 
reimbursement system for six IVF/ICSI cycles linked to the transfer policy has been set up, 
based on the clinical experience of Belgian groups (9). The arguments behind this agreement 
were diminished neonatal costs as result of reducing the twin pregnancy rate to half and the 
high order multiples to almost zero.  
 
A consortium organized by ESHRE, named EIM (European IVF Monitoring), includes 
representatives from the European countries participating in data collection. In the analysis of 
the first 15 years of EIM activity a clear trend in transferring fewer embryos has been 















Already in 2000, double embryo transfers became the most frequently used in Europe. At the 
same time, the percentage of single embryo transfers (SETs) started to increase, exceeding the 
number of three embryo transfers in 2005. The EIM repo ts are unable to discriminate 
between elective and compulsory SET, however, the increase seen in the more recent years is 
due to an overall increase of the eSET policy. When reducing the number of embryos 
transferred, the number of cryopreservation cycles increases, as also found in this report. As 
expected, the number of multiple deliveries (twins, triplets and more) decreased from 29.5% 
to 19.2% during the 15 years. The best indicator of success, the cumulative delivery rate, 
unfortunately cannot be calculated exactly based on the annual EIM reports (10).  
 
Also in US a marked and linear reduction in multiple birth rates has been seen, and 
importantly, little to no effect on clinic-level live birth rates (4). From this analysis it would 
appear that quite high rates of eSET are required if one is to effectively address the 
complication of multiple births after IVF. The higher acceptance of eSET is lies on 
improvements in embryo cryopreservation and embryo genetic analysis and selection. A study 
from US reports a 10%–15% reduction in live birth rate and at least a 47% decrease in MBR 
with SET compared with DET in the setting of favourable patient prognostic factors, 
including younger age, transfer of a blastocyst, and dditional embryos cryopreserved (11). 
 
A. Risks of multiple pregnancies  
 
Multiple pregnancies are associated with considerabl  risks for the mother and offspring as 
well as excess obstetric and neonatal costs (12). Of these risks, prematurity is the most 
important; indeed, multiple pregnancy is associated with a six-fold increase in the risk of 
preterm birth. In general, an increased risk of neurological sequelae occurs in multiple 
pregnancies. The risk for cerebral palsy even is five-to ten-fold.  In addition, prenatal and 
neonatal complications can result in health problems later in the children’s lives, including 
mental and physical disabilities (13). The cost of care for children born prematurely as a result 
of multiple births is also considerable (14).  
 
Many risks to the health of the mother are well documented. Maternal complications include 
increased risk of pregnancy-induced hypertension, pre-eclampsia, gestational diabetes, 
obstetric haemorrhage, and operative delivery. Matern l morbidity is related to the number of 















Mortality rates are also increased: stillbirths, early neonatal, late neonatal and infant mortality 
are higher in multiple pregnancies, increasing with the number of foetuses. Preterm delivery 
and low birth weight are the main factors accounting for the excess in neonatal morbidity. 
Many multiple gestation neonates require treatment and extended care in neonatal intensive 
care units, and about one-half of twins and 80% of triplets are admitted to neonatal intensive 
care units.  
 
The psychosocial aspects are important, too. The transition to parenthood is a period of 
change and stress, and even more for the parents of twins. They have to cope with two infants 
whose needs may be demanding as a result of prematurity, perinatal complications or 
disability. This may cause feelings of insufficiency and uncertainty, and can lead to increased 
parental stress, depression and anxiety. In a Finnish study, twin parenthood, but not ART, had 
a negative effect on the mental health of both mothers and fathers during the transition to 
parenthood (15). 
 
A. Prevention of multiple pregnancies in assisted r production  
 
The practice of eSET programme, which consists of transferring one single fresh embryo, 
followed by one or more frozen–thawed embryo transfer cycle(s) as needed, has reduced 
multiple pregnancy rates while maintaining acceptable cumulative live birth rates (12). 
Considerations of safety encouraged many clinics to adopt a policy of eSET. This policy was 
based on continued refinement of all stages of treatm nt, including patient counselling, 
ovarian stimulation, laboratory conditions and embryo selection. The evaluation of 
cumulative delivery rates becomes more relevant, taking into account both efficacy and 
safety. In a recent Swedish population-based registry study cumulative delivery rate per 
aspiration increased up to 20 oocytes retrieved and then evened out while the incidence of 
severe OHSS increased more rapidly from around 18 oocytes and thromboembolic events, 
although rare, occurred in particular if 15 or more ocytes are retrieved. The principal 
conclusions by the authors of this study were that live birth delivery rate after fresh cycles 
increased when up to 11 oocytes were retrieved and then levelled off while the cumulative 
delivery rate per aspiration rose up to at least 20 oocytes retrieved (16). 
 
















Success of ART has for long been focused on technical aspects of treatment: the number of 
follicles and oocytes, the fertilisation and cleavage rate. In treatment cycles in which ovarian 
stimulation in conjunction with IVF, ICSI, or both, results in a large number of fertilised 
oocytes, cryopreservation offers the opportunity to select the best embryo for fresh transfer 
and to freeze the others for later use. This optimises the clinical use of available good quality 
embryos. In general, a good stimulation is one that produces a homogeneous cohort of mature 
oocytes, with the least inconvenience and risk to the patient, and results in the birth of a 
healthy singleton (17). 
 
Non-invasive selection of developmentally competent human oocytes may increase the 
overall efficiency of human assisted reproduction. In a review Swain and Pool (18) 
summarize the short list of features of an oocyte that is regarded healthy on the basis of 
morphological investigations during the routine IVF programme: single polar body, normal-
looking cytoplasm, appropriate zona pellucida thickness, proper perivitelline space. 
According to the authors, the common experience is still that these features often fail to 
predict the future fertilizing ability and developmental competence. The following structures 
can further be investigated: meiotic spindle, vacuoles r refractile bodies, polar body shape, 
oocyte shape, dark cytoplasm or diffuse granulation, ce tral cytoplasmic granulation, 
cumulus-oocyte complex and cytoplasm viscosity and membrane resistance characteristics 
(19). However, no clear tendency in recent publications to a general increase in predictive 




Morphological assessment of preimplantation stage embryos is still one key element of the 
embryology laboratory work (20). Traditionally, identifying embryos with highest potential 
for implantation has focused on prediction models ba ed on morphological characteristics 
where routine inverted microscopic investigations are performed at predetermined 
checkpoints. At the zygote state, certain patterns of pronuclei (number and the distribution of 
nucleoli) have been found to correlate with treatment outcome in IVF and ICSI cycles, 
offering a possible prognostic tool prior to cleavage. However, it is not known whether 
indicators referring to zygote morphology are useful, especially as differences in pronuclear 
















Proposed indicators for cleavage-stage embryos are early cleavage rate, cleavage rate, embryo 
development rates, embryo fragmentation rate, and rte of good quality embryos (embryo 
score or grade). Studies have shown that early cleavage, together with other factors, can be 
used as an embryo selection method (17). A classical study (21) characterized a top quality 
embryo as follows: absence of multinucleated blastomeres, four or five blastomeres on day 2, 
seven or more cells on day 3, and </=20% anucleated fragments. A large prospective SET 
study performed with the aim of constructing an evid nce-based embryo score for the ranking 
and selection of early cleavage stage embryos shows that blastomere number, proportion of 
mononucleated blastomeres, and degree of fragmentation size have independent prognostic 
power to predict live birth (22). 
 
Delaying transfer and prolonging embryo culture to the blastocyst stage is argued to improve 
uterine and embryonic synchronicity. Assessment of blastocyst morphology is straightforward 
in the case of good quality blastocysts, but can be challenging for embryos showing an 
attempted cavitation (17). Blastocyst quality should be based on blastocoele expansion, 
appearance of trophectoderm, and appearance if inner cell mass. In a Swedish study, all three 
parameters had a significant effect on live birth. However, once adjusted for known 
significant confounders, it was shown that appearance of trophectoderm was the only 
statistically significant independent predictor of live birth outcome (23). It may be that, even 
though inner cell mass is important, a strong trophectoderm layer is essential at this stage of 
embryo development, allowing successful hatching and implantation. 
 
In another study Van den Abbeel et al. (24) assessed the ability of three individual blastocyst 
morphology parameters - expansion and hatching stage, inner cell mass grade and 
trophectoderm grade - to predict outcome of a cycle with single-blastocyst transfer. In the 
simple logistic regression analysis, all three blastocyst morphology parameters were 
statistically significantly associated with clinical and ongoing pregnancy rates and live birth 
rates, while only the inner cell mass grade was significantly associated with early pregnancy 
loss rate. Blastocyst expansion and hatching stage w s the only significant predictor of live 
birth in the multiple logistic regression. In conclusion, although all three blastocyst 
morphology parameters were related to treatment outcome of fresh single-blastocyst cycles, 
selection of high-quality blastocysts for transfer should consider first the expansion and 


















The number of cryopreservation cycles was fairly constant in Europe during the 1990s, but 
has increased over the past 20 years. Many variables may influence the outcome of embryo 
cryopreservation and frozen embryo transfer. Several r ports indicate that transfer of partially 
damaged thawed embryos results in lower pregnancy rates compared with transfer of fully 
intact embryos. Successful eSET program needs high quality cryopreservation techniques. 
Over the past decade vitrification has proved to be a successful method of blastocyst 
cryopreservation in human IVF, achieving high pregnancy and live birth rates. When 
transferring cryopreserved blastocysts, pre-freeze blastocoele expansion and trophectoderm 
grade and post-thaw degree of re-expansion seem to be the most significant predictors of live 
birth in frozen-thawed blastocyst transfer cycles (25). 
 




There is a need for secondary measures in addition to morphology that will provide precise 
physiological information about an individual embryo to facilitate selection for SET. 
Metabolomics has been proposed as a non-invasive method to assess oocyte quality, embryo 
viability, and endometrial receptivity (26). Metabolomics is defined as the non-targeted 
identification and quantification of all low molecular weight end-products of metabolism 
(metabolites). It reflects events well downstream of gene expression and gives valuable 
information about the metabolism within cells, that other ‘omics’ technologies cannot (27).  
 
The premise of any technology examining metabolic, metabolomic or proteomic differences 
between embryos is that this information provides a greater ability to establish the viable 
embryo within a cohort of good quality embryos. Near infrared (NIR) spectroscopy is a 
technology proposed to facilitate non-invasive screening for the most optimal human embryo 
for uterine transfer. It has been proposed that the NIR spectral profile of an embryo's spent 
culture medium can be used to predict the implantation potential and can serve as a method to 
compare and select between sibling embryos. As the initial proof of principle studies were all 
retrospective, NIR spectroscopy on spent embryo culture medium was investigated in an on-















transfers. The study was terminated early as the analysis of the Data Safety Monitoring Board 
showed a very low conditional power of superiority for the primary outcome (28). Thus their 
conclusion was that the addition of NIR spectroscopy t  embryo morphology does not 
improve the chance of a viable pregnancy when performing SET, and in its current form 
cannot be used as an objective marker of embryo viability. The study by Kirkegaard et al (29) 
also questions the usefulness of the entire metabolome for embryo selection, which should 
direct the search for viability markers in the culture media towards individual components.  
 
The aim of a recent systematic review was to examine the potential application of 
metabolomics to female reproduction, specifically to the metabolomics of follicular fluid, 
embryo culture medium and endometrial fluid (30). According to this review there is some 
weak evidence that metabolomics technologies studying embryo culture media might be able 
to predict the viability of individual embryos bettr than standard embryo morphology.  
However the conclusion was that there is currently o evidence that metabolomics profiling 
can improve fertility outcomes (30).  
 
All randomised controlled trials (RCTs) on metabolomic assessment of oocyte quality, 
embryo viability, and endometrial receptivity in women undergoing ART were analysed also 
in Cochrane review. They came to the same conclusion: at the moment there is no evidence to 
support or refute the use of this technique for subfertile women undergoing ART (26). 
 
B. The potential of time lapse embryo culture to improve outcomes 
 
Embryo incubation and assessment is a vital step in ART. In 2009, the first automatic time-
lapse devices became commercially available for ART clinics, moving from very primitive 
cinematography to a massive analysis of growing embryos in a few hours (31). With the 
introduction of time-lapse imaging, where an image of ach embryo is taken every 10 to 20 
minutes, more embryo parameters can be viewed while leaving the embryos in an undisturbed 
environment. There are also more commercial interests becoming involved in the production 
of equipment (32). 
 
Traditionally, embryo assessment has been achieved by removing embryos from a 
conventional incubator for assessment of under a light microscope daily. Time-lapse systems 















quality of the embryos without physically removing them from the incubator. Stable culture 
environment limits the exposure of embryos to changes in gas composition, temperature and 
movement. More frequent observations will provide substantially more information on the 
relationship between development, timing, and embryo viability (33). This could afford 
potential advantage of improving single embryo selection for ART treatment by utilising 
additional information gained through monitoring embryo development (34). However, this 
review concluded, that there is insufficient evidenc  of differences in live birth, miscarriage, 
stillbirth or clinical pregnancy to choose between time-lapse system and conventional 
incubation.  
 
As the availability of time-lapse technologies increased, attention was first focused on 
assessing their clinical safety. Once the safety had been established and the available 
technologies were validated for clinical use, research then turned to determining how the 
time-lapse imaging systems could be used to increase pregnancy rates through in-depth 
embryo analysis and an undisturbed culture system (35).
 
Standardized timing of observations is critical. As morphology and developmental 
competence is not firmly correlated, morphological assessment has limited predictive value in 
the identification of the most viable embryos. To determine whether incubation in the 
integrated EmbryoScope time-lapse monitoring system (TMS) and selection supported by the 
use of a multivariable morphokinetic model improve reproductive outcomes in comparison 
with incubation in a standard incubator and selection based exclusively on morphology was 
studied in a prospective, randomized, double-blinded, controlled study (36). They concluded 
that the strategy of culturing and selecting embryos in the integrated EmbryoScope time-lapse 
monitoring system improves reproductive outcomes. The ongoing pregnancy rate was 
statistically significantly increased 51.4% for the TMS group compared with 41.7% for the 
standard group (36). However, the project was unable to demonstrate whether the 
improvement were from the unchanging culture conditions provided by the EmbryoScope or 
the morphokinetic embryo selection algorithm applied (31). 
 
The pilot randomized controlled trial (RCT) published by Kaser et al. (37) concluded that 
adjunctive use of another time-lapse system, the Eeva test, did not improve clinical pregnancy 
rate per transfer. However, this study compared day 3 single embryo transfer with Eeva test to 















transfer with or without Eeva. In contrast, the study by Adamson et al. (38) is one of the few 
studies to directly compare day 3 embryo transfers using a TLM system against day 3 
transfers with conventional morphology analysis alone, and demonstrated significantly higher 
implantation and clinical pregnancy rates in the test group compared with controls. 
 
In contrast, in a study by Goodman et al (35) the addition of time-lapse morphokinetic data 
did not significantly improve clinical reproductive outcomes. Clinical pregnancy and 
implantation rates were similar overall and with blastocyst transfers. Clinical pregnancy rate 
with day 5 transfer was threefold higher than day 3 transfer, but the use of time-lapse system 
was not a significant predictor of implantation. In addition, the authors confirmed that the 
time of the start of blastulation, the absence of multinucleation and the use of a score based on 
morphology were significant predictors of implantation (35). 
 
Time-lapse monitoring has emerged as a novel technology to perform semi-quantitative 
evaluation of embryo morphology and developmental kinetics in assisted reproduction. While 
this method has already been introduced into clinical practice in many laboratories, it is 
unclear whether it adds value to conventional morphlogy (39). To study the efficacy of six 
embryo-selection algorithms when applied to a large, exclusive set of known implantation 
embryos a retrospective, observational analysis was carried out (40). Their data suggested that 
currently available embryo-selection algorithms may not be clinically applicable and lose 
their diagnostic value when externally applied.  
 
The remaining questions are: is blastocyst prediction clinically useful; is there any 
morphokinetic algorithm available for all time-lapse devices; can it be sold as a diagnostic 
test; regarding embryo euploidy, can it be forecast by a non-invasive morphokinetic test; and 
is time-lapse useful for selecting euploid embryos? (31). As more data become available, it is 
of the utmost importance that groups using time-lapse methods share a common nomenclature 
for measured time points. It has been proposed that until such evidence accumulates, selection 
of embryos by time-lapse should remain an experimental strategy subject to institutional 
review and approval (39).  One thing seems certain: as technology advances, the debate about 
time-lapse will not remain static. With time and exp rience, we may well come to quite 
different conclusions (41). 
 
















During recent years one important focus has been on analysis of all 24 chromosome copy 
number for evaluation and transfer of only euploid embryos, now known as preimplantation 
genetic testing for aneuploidy (PGT-A) (also known as preimplantation genetic screening; 
PGS) (42). Initially, PGT-A was performed principally on day 3 embryos, whereby a single 
blastomere was biopsied and analysed with fluorescence in situ hybridization (FISH). This 
was followed two days later with a blastocyst transfer. It took almost a decade after its clinical 
introduction before the first properly designed RCTs on this technique were published. 
Astonishingly, these did not indicate a benefit of PGT-A, but a significantly decreased chance 
on ongoing pregnancy in comparison with IVF without PGT-A (42). 
 
The Blastocyst Euploid Selective Transfer (BEST) trial enrolled IVF couples with a female 
partner up to age 42 years. They were randomized to receive transfer of a single euploid 
embryo (eSET) or to the standard of care with transfer of two embryos that were not biopsied 
(untested double embryo transfer). Among the 175 randomized patients, the delivery rates 
were similar through the fresh cycle and up to one frozen transfer (69% after euploid eSET vs 
72% after untested DET), with a dramatic difference in multiple births (1.6% vs 47%) (43). 
 
More recently, several randomized controlled studies produced evidence that day 3 biopsy 
with PGT-A is detrimental to outcome, partially due to its invasive nature and to embryo 
mosaicism (44). The mosaic nature of human preimplantation embryos at this developmental 
stage and the technique used, FISH analysis of a limited number of chromosomes, are 
considered the main reasons for the inefficacy of PGT-A (42). Newer techniques are 
substituting FISH: comparative genomic hybridization (CGH), array CGH (aCGH), digital 
polymerase chain reaction (dPCR), single-nucleotide polymorphism (SNP) array, real-time 
quantitative PCR (qPCR), and next-generation sequencing (NGS) (45). Although NGS has 
the advantage of high accuracy and decreased cost compared with aCGH, more research is 
needed to elucidate the mosaicism phenomenon further (45). Mosaicism refers to two or more 
cell populations with different chromosomal complements being present within the same 
embryo. Embryonic mosaicism is believed to be a confounder when trying to interpret PGT-A 
results. 
 
A clinical scenario in which PGT-A may be of significant benefit is to increase utilization of 















designed to decrease the number of embryos transferred in patients older than 35 years 
(Ubaldi). Elective SET was offered in patients with fewer than two implantation failures if 
favourable embryo morphology and/or PGT-A screening occurred. There were no significant 
differences in clinical pregnancy rates per transfer pr - and post-change in protocol, but there 
was a significant increase in live-birth rates per embryo transfer cycle for the eSET-PGT-A 
recipients. However, only 43.6% of PGT-A cycles had at least one euploid embryo to transfer. 
When comparing live-birth rates per cycle, there was no significant difference between groups 
(20.9% without PGT-A vs. 24.4% with PGT-A) (46) 
 
The goal of the study by Kang et al. (44) was to compare IVF outcomes between women 
undergoing frozen transfers of euploid blastocysts after PGT-A with patients undergoing fresh 
blastocyst transfers without PGT-A to determine whether routine application of this 
technology proves beneficial. They found that among women 37 years old or younger, IVF-
PGT-A does not improve live-birth rates, nor does it reduce miscarriage rates. Among women 
older than 37 years, IVF-PGT-A does improve clinical pregnancy and live-birth rates when 
the data are analysed per ET. However, when the data are analysed per retrieval, this 
advantage does not persist (44). And they conclude: the universal application of PGT-A adds 
extra cost and invasiveness with limited benefit, especially in younger women.  
 
ASRM states recently (45): The value of preimplantation genetic testing for aneuploidy 
(PGT-A) as a screening test for IVF patients has yet to be determined. Several studies 
demonstrate higher birth rates after aneuploidy testing and eSET, suggesting the potential for 
this testing to decrease the risk of multiple gestations, though these studies have important 
limitations. At present, however, there is insufficient evidence to recommend the routine use 
of blastocyst biopsy with aneuploidy testing in all infertile patients.  
 
A. eSET and pregnancy outcome - The Finnish experience 
 
In Finland the implementation of eSET started in 1997. In the beginning this was 
recommended to women in whom a twin pregnancy could be predicted to carry high obstetric 
risks. The results of eSET in these special groups f atients were encouraging (47). The 
results of these initial data revealed a different prognosis between eSET and cases of SET 
when only one embryo was available. In a prospectiv randomized study carried out in three 















pregnancy rate per patient after the transfer of fresh and frozen embryos was 47.3% (48).  In 
Helsinki University Hospital we analysed in a follow-up study all embryo transfers carried 
out at our clinic between 1998 and 1999. The contribu ion of embryo cryopreservation in 
eSET cycles resulted in the cumulative delivery rate of 52.8% per oocyte retrieval after fresh 
and frozen transfers (49). Indeed, we could report halving of twinning rates while maintaining 
very acceptable pregnancy rates (50). This was possible with by improving embryo selection 
methods and acknowledging the benefit of embryo crypreservation on the cumulative 
pregnancy rates. It is obvious that a significant effect of eSET is an increase in the number 
and quality of embryos available for cryopreservation. We also showed that SET policy can 
be adopted into cryopreservation programme (51). 
 
In Finland the initiative for reducing the number of transferred embryos came first from a few 
IVF clinics. Our experience confirms that the practice of reducing the number of transferred 
embryos can be implemented not only among single clinics, but also across the whole 
country. The decrease in multiple deliveries results in an improvement of the perinatal health 
of the IVF children, thus it is also important to cnsider the overall beneficial health-
economic impact. Nowadays, in Finland, SET is practiced in 80% of the cycles and even 
100% in some clinics.  
 
According to the Finnish IVF registry the proportion f single-embryo transfers has increased 
steadily every year since 1997, both in fresh and frozen embryo transfers (Fig 1). The effect 
of this is reflected in the significant decrease in the proportion of twin deliveries after ART in 
our country (Fig 2) as well as in the proportion of multiple deliveries in the whole country 
(Fig 3). This means that most ART children are born full-term (Fig 4).  
 
A. Conclusion  
 
The clinical risks to mothers and babies associated with ART multiple birth pregnancies are 
well described and widely recognized. A meta-analysis of individual patient data from 
randomized trials shows that elective SET results in a higher chance of delivering a term 
singleton live birth compared with double embryo transfer. Although this strategy yields a 
lower pregnancy rate than a double embryo transfer in a fresh IVF cycle, this difference is 















strategy to a large extent overcomes the problems associated with multiple pregnancies and is 
now used in many countries.  
 
Nordic population-based matched cohort study based on ata from more than 92 000 ART 
children shows that the perinatal outcomes after ART have improved over the last 20 years, 
mainly due to the reduction of multiple births. Also for singletons conceived after ART, a 
remarkable decline in the risk of being born preterm and very preterm was observed. Data 
from these four countries confirm an overall improvement over time in the perinatal outcomes 
of ART children. Especially this study show the beneficial effect of single embryo transfer, 
not only in regard to lowering the rate of multiples but also concerning the health of 
singletons (53). 
 
The few economic analyses that do exist consistently demonstrate the greater patient, 
healthcare and societal costs associated with twins and higher-order multiples when compared 
with singleton infants, and convincingly add to theargument that single embryo transfer 
should be standard practice (54). A recent review of the key studies on the costs and 
consequences of ART treatment, specifically examined economic drivers of utilisation and 
clinical practice. The level of affordability of ART treatment is an important driver of 
treatment choices, embryo transfer practices and ultimately multiple birth rates (55). The 
decrease in multiple deliveries results in an improvement of the perinatal health of the IVF 
children and the wellbeing of the families. A healthy singleton delivery should be the goal of 



















- Multiple birth rates after ART depend on the number of embryos transferred 
- Twin birth rates still vary widely from country to country, from as low as 5 % to as 
high as 30%. 
- Multiple pregnancies are associated with considerabl  risks for the mother and off-
spring as well as excess obstetric and neonatal costs
- Twin pregnancy rates can be lowered considerably with increasing use of elective 
single embryo transfer and cryopreservation of extra embryos 
- Selection of the best embryo for transfer could be improved by using new techniques, 
including blastocyst culture, possibly by time-lapse monitoring or genetic assessment 




- Future large cohort studies must publish complete da asets including cumulative live 
birth rates per started IVF stimulation  
- Long follow-up studies on the health of children con eived with specified new 
techniques are important 
- All new techniques must be studied both for safety and efficiency prior to routine 
adoption in the ART laboratory, including cost analyses of healthcare resources.  
- Especially PGT-A must be addressed by further reseach include: cost-effectiveness; 
the role and effect of cryopreservation, utility in specific subgroups  
- Large, prospective, well-controlled studies evaluating he combination of multiple 
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